Tocilizumab Monotherapy Versus Adalimumab Monotherapy for Treatment of Rheumatoid Arthritis (ADACTA): A Randomised, Double-Blind, Controlled Phase 4 Trial
Risankizumab Compared With Adalimumab in Patients With Moderate-to-Severe Plaque Psoriasis (IMMvent): A Randomised, Double-Blind, Active-Comparator-Controlled Phase 3 Trial
Adjustment of Therapy in Rheumatoid Arthritis on the Basis of Achievement of Stable Low Disease Activity With Adalimumab Plus Methotrexate or Methotrexate Alone: The Randomised Controlled OPTIMA Trial
Adalimumab
Efficacy and Safety of Adalimumab Every Other Week Versus Methotrexate Once Weekly in Children and Adolescents With Severe Chronic Plaque Psoriasis: A Randomised, Double-Blind, Phase 3 Trial
Adalimumab for Prevention of Uveitic Flare in Patients With Inactive Non-Infectious Uveitis Controlled by Corticosteroids (VISUAL II): A Multicentre, Double-Masked, Randomised, Placebo-Controlled Phase 3 Trial
Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Patients With Non-Radiographic Axial Spondyloarthritis (ABILITY-3): A Multicentre, Randomised, Double-Blind Study
Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study